Optelian Releases OMS-719 Optical Networking Platform for Next Generation Optical Transport Capabilities

Optelian, a trusted optical transport system manufacturer, today announced the introduction of its new OMS-719 Optical Networking Platform that supports next generation Optical Transport capabilities.

This comprehensive new platform is highly energy efficient offering low power consumption, providing Optelian customers a "green" system that is scalable and flexible. The multi-reach, (Access Metro and Long-haul) platform offers a compact footprint and high port density.

In addition to its well known portfolio of DWDM and CWDM solutions, Optelian recently added ROADM, Muxponders, OTN, and Ethernet VLAN switching to its LightGAIN optical networking system. Optelian is increasing its DWDM channel count to eighty, adding higher powered amplifiers and multi-degree ROADMs, as well as a variety of new Muxponder configurations. The OMS-719 universal platform supports all of these new capabilities, and conforms to both North American and ETSI mounting standards.

"Our customers are demanding more from their optical networks," said David Mills, VP sales for Optelian. "They want higher bandwidth along with increased visibility and management at the optical level while, at the same time they need to reduce operating cost and complexity. Optelian's new platform provides a simple and affordable solution for network operators to meet these challenges."

The OMS-719 platform is fully compatible with existing LightGAIN optical modules, and can be either convection or fan cooled depending on the chosen configuration.

Source: http://www.optelian.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.